Safety of Paxlovid Among Patients with Moderate or Severe Hepatic or Renal Impairment

14/12/2022
29/10/2026
EU PAS number:
EUPAS50123
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

C4671047_PROTOCOL_V1_16NOV2022

English (3.98 MB - PDF) View document
Updated protocol

C4671047_PROTOCOL AMENDMENT 2_V3_21JUN2023_SIGNED

First published: 22/02/2024
English (1.32 MB - PDF) View document
Study results
No information provided.
Study report
Abstract of study report

c4671047-abstract.pdf

English (684.49 KB - PDF) View document
Other information
Study, other information

1047_DeclarationofInterests_combined.pdf

English (2.79 MB - PDF) View document

1047_DeclarationofInterests-Annex5_template _Muhammad Younus.pdf

English (104.35 KB - PDF) View document

1047_DeclarationofInterests_combined_Updates _EUPAS 50123.pdf

English (456.98 KB - PDF) View document
ENCePP Seal
No information provided.